The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Norethindrone Acetate ID: ALA4091490
Cas Number: 38673-38-0
PubChem CID: 63021
Max Phase: Preclinical
Molecular Formula: C22H28O3
Molecular Weight: 340.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C#C[C@@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
Standard InChI: InChI=1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22+/m0/s1
Standard InChI Key: IMONTRJLAWHYGT-REGVOWLASA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
12.6436 -12.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6436 -13.3146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5141 -14.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9361 -13.7165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2239 -13.3245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5141 -13.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7943 -14.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9337 -12.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2140 -12.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9478 -14.5484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7863 -13.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2380 -14.9742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0832 -14.5644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3686 -14.9761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0844 -13.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4986 -11.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2239 -14.1481 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
10.5141 -12.9110 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
11.9361 -12.8929 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12.6436 -14.1382 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
13.4310 -13.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9174 -12.9006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4310 -12.2329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2162 -11.4351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0055 -10.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1456 -11.8211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8561 -12.2329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5708 -11.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8561 -13.0564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 12 1 0
4 2 1 0
5 4 1 0
6 5 1 0
7 3 2 0
8 1 1 0
9 8 1 0
10 4 1 0
11 6 1 0
12 10 1 0
13 7 1 0
14 13 2 0
15 11 1 0
1 16 1 1
5 17 1 6
6 18 1 1
4 19 1 1
2 20 1 6
9 5 1 0
3 6 1 0
13 15 1 0
2 21 1 0
21 22 1 0
22 23 1 0
23 1 1 0
23 24 1 1
24 25 3 0
23 26 1 0
26 27 1 0
27 28 1 0
27 29 2 0
M END Associated Targets(Human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.46Molecular Weight (Monoisotopic): 340.2038AlogP: 4.06#Rotatable Bonds: 1Polar Surface Area: 43.37Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.66CX LogD: 3.66Aromatic Rings: ┄Heavy Atoms: 25QED Weighted: 0.53Np Likeness Score: 1.97
References 1. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101 ] [10.1093/toxsci/kft176 ] 2. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801 ] [10.1016/j.drudis.2016.02.015 ]